Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
InMode Ltd. stock logo
INMD
InMode
$14.35
-2.1%
$15.20
$13.68
$19.85
$907.05M2.021.19 million shs1.04 million shs
Iradimed Corporation stock logo
IRMD
Iradimed
$57.79
-0.2%
$52.40
$41.69
$63.29
$734.80M0.9143,218 shs76,983 shs
SI-BONE, Inc. stock logo
SIBN
SI-BONE
$18.86
-0.2%
$15.62
$11.70
$20.05
$803.72M0.82378,049 shs417,863 shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$9.01
-1.4%
$9.30
$8.15
$22.40
$250.90M2.16212,382 shs131,691 shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
InMode Ltd. stock logo
INMD
InMode
0.00%+3.23%+0.82%-22.23%-23.21%
Iradimed Corporation stock logo
IRMD
Iradimed
0.00%+13.72%+8.66%+9.03%+36.80%
SI-BONE, Inc. stock logo
SIBN
SI-BONE
0.00%+2.61%+34.81%+7.34%+34.23%
ZimVie Inc. stock logo
ZIMV
ZimVie
0.00%+10.63%-2.14%-32.05%-44.98%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
InMode Ltd. stock logo
INMD
InMode
3.8371 of 5 stars
4.13.00.00.03.41.71.9
Iradimed Corporation stock logo
IRMD
Iradimed
4.7193 of 5 stars
2.53.02.54.43.53.31.9
SI-BONE, Inc. stock logo
SIBN
SI-BONE
3.8515 of 5 stars
2.53.00.03.34.02.50.6
ZimVie Inc. stock logo
ZIMV
ZimVie
2.4555 of 5 stars
3.33.00.00.02.61.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
InMode Ltd. stock logo
INMD
InMode
2.13
Hold$18.5429.21% Upside
Iradimed Corporation stock logo
IRMD
Iradimed
3.00
Buy$72.0024.59% Upside
SI-BONE, Inc. stock logo
SIBN
SI-BONE
3.00
Buy$22.5019.30% Upside
ZimVie Inc. stock logo
ZIMV
ZimVie
2.67
Moderate Buy$16.3381.28% Upside

Current Analyst Ratings Breakdown

Latest ZIMV, INMD, SIBN, and IRMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/15/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$16.00 ➝ $10.00
5/6/2025
SI-BONE, Inc. stock logo
SIBN
SI-BONE
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$20.00 ➝ $22.00
5/6/2025
SI-BONE, Inc. stock logo
SIBN
SI-BONE
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$25.00 ➝ $25.00
5/6/2025
SI-BONE, Inc. stock logo
SIBN
SI-BONE
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$24.00 ➝ $24.00
4/30/2025
InMode Ltd. stock logo
INMD
InMode
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$29.00 ➝ $24.00
4/29/2025
InMode Ltd. stock logo
INMD
InMode
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$19.00 ➝ $16.25
4/29/2025
InMode Ltd. stock logo
INMD
InMode
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$17.00 ➝ $15.00
4/29/2025
InMode Ltd. stock logo
INMD
InMode
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
4/28/2025
InMode Ltd. stock logo
INMD
InMode
Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
4/28/2025
InMode Ltd. stock logo
INMD
InMode
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Neutral$22.00 ➝ $16.00
4/28/2025
InMode Ltd. stock logo
INMD
InMode
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
(Data available from 6/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
InMode Ltd. stock logo
INMD
InMode
$392.41M2.31$1.38 per share10.40$10.12 per share1.42
Iradimed Corporation stock logo
IRMD
Iradimed
$75.15M9.78$1.44 per share40.12$5.66 per share10.21
SI-BONE, Inc. stock logo
SIBN
SI-BONE
$176.60M4.55N/AN/A$4.18 per share4.51
ZimVie Inc. stock logo
ZIMV
ZimVie
$443.55M0.57$3.25 per share2.77$15.43 per share0.58
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
InMode Ltd. stock logo
INMD
InMode
$181.27M$2.336.117.88N/A45.91%18.25%16.33%8/7/2025 (Estimated)
Iradimed Corporation stock logo
IRMD
Iradimed
$19.23M$1.5538.5328.90N/A26.26%24.12%21.20%7/30/2025 (Estimated)
SI-BONE, Inc. stock logo
SIBN
SI-BONE
-$43.34M-$0.64N/AN/AN/A-23.82%-22.51%-16.53%8/4/2025 (Estimated)
ZimVie Inc. stock logo
ZIMV
ZimVie
-$393.28M-$0.71N/AN/A-77.31%2.90%1.17%8/7/2025 (Estimated)

Latest ZIMV, INMD, SIBN, and IRMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.21$0.27+$0.06-$0.05$113.10 million$112.00 million
5/5/2025Q1 2025
SI-BONE, Inc. stock logo
SIBN
SI-BONE
-$0.24-$0.15+$0.09-$0.15$45.13 million$47.29 million
4/28/2025Q1 2025
InMode Ltd. stock logo
INMD
InMode
$0.45$0.31-$0.14$0.26$82.21 million$77.87 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
InMode Ltd. stock logo
INMD
InMode
N/AN/AN/AN/AN/A
Iradimed Corporation stock logo
IRMD
Iradimed
$0.681.18%N/A43.87%1 Years
SI-BONE, Inc. stock logo
SIBN
SI-BONE
N/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A

Latest ZIMV, INMD, SIBN, and IRMD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/5/2025
Iradimed Corporation stock logo
IRMD
Iradimed
quarterly$0.171.3%5/20/20255/20/20255/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
InMode Ltd. stock logo
INMD
InMode
N/A
10.23
9.38
Iradimed Corporation stock logo
IRMD
Iradimed
N/A
9.21
7.82
SI-BONE, Inc. stock logo
SIBN
SI-BONE
0.22
8.25
7.22
ZimVie Inc. stock logo
ZIMV
ZimVie
0.57
1.94
1.38

Institutional Ownership

CompanyInstitutional Ownership
InMode Ltd. stock logo
INMD
InMode
68.04%
Iradimed Corporation stock logo
IRMD
Iradimed
92.34%
SI-BONE, Inc. stock logo
SIBN
SI-BONE
98.11%
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%

Insider Ownership

CompanyInsider Ownership
InMode Ltd. stock logo
INMD
InMode
6.92%
Iradimed Corporation stock logo
IRMD
Iradimed
36.80%
SI-BONE, Inc. stock logo
SIBN
SI-BONE
4.00%
ZimVie Inc. stock logo
ZIMV
ZimVie
3.01%
CompanyEmployeesShares OutstandingFree FloatOptionable
InMode Ltd. stock logo
INMD
InMode
48063.21 million64.75 millionOptionable
Iradimed Corporation stock logo
IRMD
Iradimed
11012.72 million7.97 millionOptionable
SI-BONE, Inc. stock logo
SIBN
SI-BONE
35042.62 million40.30 millionOptionable
ZimVie Inc. stock logo
ZIMV
ZimVie
2,70027.85 million26.77 millionOptionable

Recent News About These Companies

Q1 2025 ZimVie Inc Earnings Call
ZimVie announces launch of its Immediate Molar Implant system in US
ZimVie launches molar implant system
Needham Remains a Hold on ZimVie Inc (ZIMV)

New MarketBeat Followers Over Time

Media Sentiment Over Time

InMode stock logo

InMode NASDAQ:INMD

$14.35 -0.31 (-2.11%)
Closing price 04:00 PM Eastern
Extended Trading
$14.34 -0.01 (-0.10%)
As of 04:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

Iradimed stock logo

Iradimed NASDAQ:IRMD

$57.79 -0.09 (-0.16%)
Closing price 04:00 PM Eastern
Extended Trading
$57.87 +0.08 (+0.14%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

SI-BONE stock logo

SI-BONE NASDAQ:SIBN

$18.86 -0.04 (-0.21%)
Closing price 04:00 PM Eastern
Extended Trading
$18.86 0.00 (-0.03%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

$9.01 -0.13 (-1.42%)
Closing price 04:00 PM Eastern
Extended Trading
$9.02 +0.01 (+0.06%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.